Back

Low-density lipoprotein cholesterol increased significantly after short-term discontinuation of atorvastatin, but did not correlate with plasma drug concentrations

8 April 2022 (15:23 - 15:32)
Organised by:
Congress Presentation Part of: Rapid fire abstracts session 2 - Primary Care and Risk Factor Management Lipid-Lowering Agents EAPC Premium Access ESC Preventive Cardiology 2022

About the speaker

Photo
Mr Jonas Pivoriunas

Vestre Viken HF, Drammen (Norway)

4 More presentations in this session

Presentation thumbnail
Long-term effect of obstructive sleep apnea and CPAP treatment on blood pressure control in patients after acute coronary syndrome
Doctor A. Aldoma (Lleida, ES)
Abstract Slides Video
Presentation thumbnail
Anxiety and depressive symptoms in patients with common cardiovascular diseases during hospitalization for COVID-19
Presentation thumbnail
HDL 3: a link between atherosclerosis and thrombosis?
Presentation thumbnail
Meta-analysis of randomized controlled trials examining the safety and efficacy of bempedoic acid
Doctor L. Borgatta (Hershey, US)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid fire abstracts session 2 - Primary Care and Risk Factor Management

The Event

Event poster

ESC Preventive Cardiology 2022

8 April 2022 15:23 CET
You may be interested in
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources